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Abstract
Purpose Minimally invasive treatment of solid cancers,
especially in the breast and liver, remains clinically chal-
lenging, despite a variety of treatment modalities, including
radiofrequency ablation (RFA), microwave ablation or high-
intensity focused ultrasound. Each treatment modality has
advantages and disadvantages, but all are limited by place-
ment of a probe or US beam in the target tissue for tumor
ablation and monitoring. The placement is difficult when the
tumor is surrounded by large blood vessels or organs. Patient-
specific image-based 3D modeling for thermal ablation sim-
ulation was developed to optimize treatment protocols that
improve treatment efficacy.
Methods A tissue-mimicking breast gel phantom was used
to develop an image-based 3D computer-aided design (CAD)
model for the evaluation of a planned RF ablation. First, the
tissue-mimicking gel was cast in a breast mold to create a 3D
breast phantom, which contained a simulated solid tumor.
Second, the phantom was imaged in a medical MRI scan-
ner using a standard breast imaging MR sequence. Third, the
MR images were converted into a 3D CAD model using com-
mercial software (ScanIP, Simpleware), which was input into
another commercial package (COMSOL Multiphysics) for
RFA simulation and treatment planning using a finite element
method (FEM). For validation of the model, the breast phan-
tom was experimentally ablated using a commercial (RITA)
RFA electrode and a bipolar needle with an electrosurgi-
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cal generator (DRE ASG-300). The RFA results obtained by
pre-treatment simulation were compared with actual experi-
mental ablation.
Results A 3D CAD model, created from MR images of the
complex breast phantom, was successfully integrated with
an RFA electrode to perform FEM ablation simulation. The
ablation volumes achieved both in the FEM simulation and
the experimental test were equivalent, indicating that patient-
specific models can be implemented for pre-treatment plan-
ning of solid tumor ablation.
Conclusion A tissue-mimicking breast gel phantom and its
MR images were used to perform FEM 3D modeling and
validation by experimental thermal ablation of the tumor.
Similar patient-specific models can be created from preop-
erative images and used to perform finite element analy-
sis to plan radiofrequency ablation. Clinically, the method
can be implemented for pre-treatment planning to pre-
dict the effect of an individual’s tissue environment on
the ablation process, and this may improve the therapeutic
efficacy.
Keywords Radiofrequency ablation · Image-based 3D
modeling · FEM simulation · Cancer treatment
Introduction
Death from invasive cancer remains one of the leading causes
of human mortality and underlies the extensive research for
the development of more effective therapies to improve sur-
vival. The minimally invasive nature of thermal ablation (the
heating of tissue to induce death) makes it a popular choice
for cancer treatment especially when surgical resection is
not possible or contraindicated [1,2]. However, the clinical
application of minimally invasive treatment modalities [3]
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such as radiofrequency ablation (RFA), microwave ablation
(MWA) or high-intensity focused ultrasound (HIFU) remains
challenging as the efficacy depends on accurate placement of
the probe or focusing the HIFU at the target tissue to pro-
vide the necessary volumetric heating, which in turn is influ-
enced by the surrounding environment, for example, large
blood vessels causing a heat-sink effect, or adjacent organs
that have to be spared. The problem is further confounded
by the difficulty of monitoring the ablation process itself
[4,5]. Patient-specific image-based 3D modeling could
resolve these problems by permitting pre-treatment plan-
ning of the simulated thermal ablation based on preoperative
images of the lesion [6].
Radiofrequency ablation (RFA) is a proven, effective
method for targeted tumor ablation without causing signifi-
cant damage to surrounding healthy tissues [7]. RFA is based
on the principle that radiofrequency currents induce heating
in the tissue. If the temperature of the tumor is raised above
45 ◦C for 4 min, thermal necrosis of the lesion ensues. Radio-
frequency currents are introduced in the tumor tissue either
percutaneously or by a laparoscopic approach. More clin-
ical trials are currently being conducted and mathematical
computational models developed to further understand the
ablation process and the role of the surrounding tissue and
its influence on heat distribution [8]. Most of the reported
computational models [9,10] are simplified geometric sys-
tems that, though good enough to estimate ablation in FEM
studies, do not model the effect of the tissue environment
surrounding the tumor.
Human anatomical 3D computer-aided design (CAD)
models can be used to perform more complex studies on
ablation, which incorporate the surrounding healthy tissues
in addition to the tumor. These models can be created by
employing a patient’s magnetic resonance (MR) or com-
puted tomography (CT) image slices [11] to construct rep-
resentations of the actual cancer and its surrounding envi-
ronment. Such models should improve understanding of the
thermal ablation process and could help the surgeon to plan
the ablation procedure based on individual patient require-
ments, thereby improving patient outcome [12].
As patient data and images were not available for the
study, we used a tissue-mimicking gel [13] that was made
in-house for the RFA study. MR images of a gel breast
phantom were obtained and used to reconstruct an anatom-
ical 3D CAD model for the proposed study. One advan-
tage of using the gel material is that it is transparent
at room temperature and becomes opaque when coagu-
lated by heating. Moreover, it has a stable structure at
higher temperatures and does not collapse or melt. The gel
breast phantom was subsequently ablated experimentally
using a commercial RFA electrode, allowing comparison
between the RFA FEM simulations and actual experimental
ablation.
Table 1 The recipe for tissue-mimicking phantom gel (1 L with pH of
4.3)
Ingredients Dosage
Citric acid monohydrous 24.90 g
Sodium citrate tribasic dehydrate 23.97 g
Acrylamide 80.00 g
N ,N ′-methylene-bis-acrylamide 4.00 g
BSA lyophilized powder 20.00 g
Glycerol 60 mL
Deionized water Top up to 1.0 L
Initiator-activator pair
l-ascorbic acid 1.0 g
1 % FeSO4 2.5 mL
3 % H2O2 3.0 mL
Materials and methods
Tissue-mimicking gel breast phantom
The materials used to fabricate a tissue-mimicking gel phan-
tom mainly included polyacrylamide mixed with bovine
serum albumin (BSA), a protein used as a temperature-sen-
sitive indicator. The mixture was subsequently polymerized
using a reaction initiator-activator pair [13]. Table 1 shows
the recipe for 1 L of phantom gel with a citrate buffer at a
concentration of 0.2 M and pH of 4.3. The gel properties
at this pH are reported to mimic human soft-tissue prop-
erties with a coagulation temperature of 50 ◦C (gel turns
opaque), although the coagulation temperature of the gel can
be adjusted in the range 50–60 ◦C by changing its pH with
the addition of the citrate buffer [13]. A plastic breast mold
of 400 mL was used to cast the gel breast phantom, and a
small irregular-shaped portion of fresh baby potato (maximal
dimension of 25 mm) was embedded inside the phantom to
simulate cancerous tissue. In order to avoid any protein dena-
turation resulting from the high temperature generated by the
gel polymerization, the breast mold was placed in ice water
during the casting process, which normally took about 2 h.
MR imaging of the breast phantom
The gel breast phantom was then imaged in-house using
a medical GE SignaHDx1.5 Magnetic resonance imaging
(MRI) scanner (GE, Milwaukee, WI, USA). The phantom
was positioned in the middle of an 8-channel head coil,
and a total of 59 axial T2-weighted images were acquired
using Fast Spin Echo MRI sequence (FSE-XL/90) with
the following parameters: repetition time (TR) = 6,100 ms;
echo time (TE) = 116 ms; field of view (FOV) of 130 mm;
acquisitionmatrix = 256 × 256 and number of excitations
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(NEX) = 2. The slice thickness was 2 mm with zero spacing
and bandwidth (BW) = 20.8 kHz. The total acquisition time
was 6 min 43 s. Once the images were acquired, they were
exported in DICOM format for further image processing and
analysis.
Image-based 3D CAD model
The DICOM-compatible image slices were imported into
ScanIP (v4.2, Simpleware, Ltd) for preprocessing prior to
implementing the RFA FEM simulation in COMSOL Mul-
tiphysics (Comsol, UK). The imported image slices were
first cleaned with Gaussian filters to remove background
noise and then segmented to identify the simulated tumor
and healthy tissue (i.e., the gel) by selecting image contrast
boundaries. This operation enabled differentiation of tumor
from the tissue by categorizing them with different masks.
After threshold selection, the masks were subsequently used
in a flood-fill operation during the reconstruction of the
model [14]. Thereafter, the model was subjected to volumet-
ric meshing before it was exported for use by other CAD or
FEM packages. In this study, we have performed volumetric
meshing and exported the mesh as both a *.mphtxt file for
importing into COMSOL Multiphysics FEM package and a
*.stl file for CAD design using SolidWorks (Dassault Sys-
tèmes, MA, USA).
For images of more complicated structures such as
patients’ breast, liver or brain, ScanIP provides various image
processing tools to extract whole or particular components
of the imaged anatomy. This enables the user to remove the
tumor from the surrounding tissue or to identify blood vessels
or other organs using a threshold operation. Once the model
is converted into FEM-compatible file, it is imported to the
designated software where it is integrated with a selected can-
cer treatment modality such as an RFA electrode for further
FEM analysis.
RFA FEM simulation and experimental evaluation
A commercial radiofrequency interstitial tumor ablation
(RITA) probe (StarBurst Radiofrequency Ablation, Angio-
Dynamics) was used to validate the model. The RITA probe
used was a 4 tine multiprong electrode of 15 Gauge [9,15].
The electrode is disposable and monopolar. The electrode in
its expanded state was re-drawn in COMSOL and merged
with the imported 3D anatomical model, where the electrode
could be rotated and moved in the model to align its position
in relation to the tumor. Once the electrode was positioned in
the tumor, boundary and sub-domain conditions were iden-
tified and assigned. Thereafter, the model was ready to sim-
ulate the ablation process for any duration determined by the
selected treatment protocol.
A bipolar RFA needle of 3 mm diameter [16] was
re-designed and made in-house with a reduced 25- mm active
(conducting) bipolar applicator, including a 5- mm insula-
tor at the center to separate the two electrodes. This sim-
plified bipolar needle (without internal cooling) was also
used to compare results between simulated and experimental
ablation.
FEM modeling and RFA simulation
COMSOL Multiphysics, which can solve the bio-heat trans-
fer model and the electrical heating model simultaneously,
was used to perform FEM analysis, thus enabling RFA sim-
ulation. In particular, Penne’s equation (1) below was used




+ ∇.(−k∇T )=ρbCbωb(Tb − T ) + Qmet + Qext
(1)
where ρ indicates tissue density in (kg m−3), C indicates spe-
cific heat capacity of tissue at constant pressure (J kg−1 K−1),
k indicates thermal conductivity (W m−1 K−1), T is tempera-
ture (K), ρb indicates density of blood (kg m−3), Cb indicates
specific heat of blood (J kg−1 K−1), ωb indicates blood per-
fusion (= 6.4e−3 1/s), and Tb indicates temperature of blood
(K). Term Qmet indicates contribution of heat due to tissue
metabolic activities, and Qext indicates heat source due to
external RF spatial heating source (W m−3) [9,15].
At the frequencies employed in RFA (e.g., 300–500 kHz)
and within the area of interest, a high electrical current den-
sity is deposited within a small radius around the active
Table 2 Material properties
















Gel 1,069 3,676 0.59 0.117
Breast tissue 1,060 2,770 0.499 0.28
Breast tumor 1,050 3,770 0.48 0.71
Electrode 6,450 840 18 108
Trocar tip 7,900 132 71 4 × 106
Trocar base 70 1,045 0.026 10−5
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Fig. 1 Image-based 3D model: a photograph of a gl breast phantom with simulated cancerous tissue; b one selected MRI slice (#32); c segmentation
mask of slice #32; d final 3D model of the gel breast phantom reconstructed from MRI slices (transparent view of the embedded simulated cancer)
electrode and the tissue can thus be simplified as purely resis-
tive since the displacement currents are negligible. Using a
quasi-static approach, the distributed heat source Qext (Joule
loss) is given by
Qext = J · E (2)
where J is the current density (A m−2), and E is the electric
field (V m−1). The values of these two vectors are derived
from solving Laplace’s equation below
∇ · (σ∇V ) = 0 (3)
where σ stands for electrical conductivity of tissue (S m−1),
and V is the applied voltage (V). Equations (1–3) were solved
simultaneously by COMSOL Multiphysics with electrical
and thermal material properties given in Table 2 for the tis-
sue, tumor and electrode. Since the heat generated by tissue
metabolic activities is significantly smaller than the RF heat
source, we set Qmet = 0. The simulation conditions include
time-dependent processing with the direct (UMFPACK) lin-
ear system solver and non-symmetric matrix conditions. The
simulation results display the heat distribution during the
ablation process.
RFA experiment
The same phantom gel and breast phantom were used to
perform experimental validation of the planned RF ablation,
using the same RITA monopolar electrode and the bipolar
needle, powered by a commercial electrosurgical RF gen-
erator (DRE ASG-300, DREMED, 1800 Williamson Court,
Louisville, USA). The generator has the capability of deliv-
ering 120 W up to 1,000 when used in pinpoint coagulation
monopolar operation and 40 W up to 500 for bipolar mode
at a frequency of 490 ± 5 kHz.
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Fig. 2 Real-time temperature
plot during FEM RF ablation
simulation: a 3D FEM model in
Point Mode for selected points
(highlighted in red); b plot of
temperature increase against
treatment time (s) at electrodes



















Image-based 3D anatomical model
Figure 1 shows the modeling steps and results concerning
fabrication of the gel breast phantom (Fig. 1a), an MR image
of the phantom with one selected slice (Fig. 1b), segmenta-
tion for differentiating tissues (Fig. 1c) and reconstruction
of the 3D anatomical model from the MR images (Fig. 1d).
In this study, the final reconstructed 3D model (ScanIP) was
exported as *.stl mesh file that was then converted into a para-
solid geometry in SolidWorks. This extra step was included to
reduce the number of boundary elements and use of computer
memory, resulting in faster computation of the simulation.
FEM RFA simulation
The parasolid geometry of the 3D model was imported into
COMSOL Multiphysics and merged with the RFA electrode
geometry. Here, the electrode can be moved and rotated
around to obtain the ideal position for deployment of the
electrode inside the tumor (Figs. 2a, 3a). Once the insertion
and deployment of the electrode within the 3D anatomy was
achieved, the assembly was converted into a single composite
geometry for assigning the simulation boundary conditions.
The material properties shown in Table 2 were used in this
modeling, and the composite geometry was meshed coarsely
to reduce the computation time. The final mesh consists of
26,459 elements. Simulated RF ablation was then performed
with these tissue properties and the selected power and treat-
ment time.
The ablation simulation stopped automatically when
one of the following two pre-set conditions was achieved:
(i) the maximal temperature reached a selected threshold
(e.g., 100 ◦C), or (ii) the RF energy dose was completed.
A real-time temperature plot at selected points on the model
(Fig. 2a) could be displayed (Fig. 2b) to assist monitoring
of the ablation process, for example, to monitor when the
temperature at the tumor edges had increased above 50 ◦C
(T3 and T4). The simulation showed that at this applied RF
energy of 7.5 kJ, the maximal temperature at electrode T1
was below 100 ◦C. This is important because of the need to
avoid tissue carbonization that impedes or even blocks the
RF current and heat transfer into the tissue [10].
In addition to choosing probe trajectories for deployment
and keeping maximal ablation temperature below 100 ◦C,
optimization of the applied energy (i.e., the power and treat-
ment time) in the simulation was dictated by the following
criteria: (i) total ablation of tumor and (ii) minimal collateral
damage to the surrounding healthy tissue [18]. One opti-
mal simulation case is outlined below. The RITA probe was
deployed at a preferred location in the tumor (Fig. 3a), at
an applied energy of 7.5 kJ (i.e., 25 W and 300 s). We esti-
mated the ablated tissue boundary using an iso-thermal sur-
face plot for a tissue temperature of 50 ◦C and above (Fig. 3b).
From visual inspection, it is evident that the ablation volume
encompasses the entire tumor (criterion 1). As for criterion 2,
given the irregular tumor shape and the limitation of the fixed-
distance probe electrode deployment, healthy tissue might be
damaged to ensure a safe margin.
The bipolar needle probe was deployed in the tumor
(Fig. 3c), and one applied energy dose of 2.25 kJ (i.e., 7.5 W
and 300 s) was chosen after the optimization process as
described earlier. Again the ablated tissue volume was esti-
mated using an iso-thermal surface plot for a tissue temper-
ature of 50 ◦C and above (Fig. 3d). In this instance, visual
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Fig. 3 Anatomical 3D
modeling and simulation of
RFA using COMSOL
Multiphysics with breast tissue
and tumor material properties
(Table 2): a composite model
geometry with RITA monopolar
probe inserted and deployed into
the simulated tumor tissue; b
with an applied power of 25 W,
the iso-thermal surface plot of
50 ◦C indicating the ablation
volume at 5 min, which
encompassed whole tumor with
a safe margin; c bipolar RFA
needle placed within the model;
and d bipolar ablation zone with
iso-thermal surface plot at
50 ◦C: after treatment for 300 s
at 7.5 W, the iso-thermal surface
did not encompass whole tumor
















plot at 50 ºC  
Iso-thermal 
plot at 50 ºC  
inspection shows that the ablation volume did not cover the
entire tumor (criterion 1). Two bipolar needles were needed
to encompass the full extent of the tumor [4].
The simulation on the model was performed using both
breast tissue and tumor tissue properties and included the
effect of perfusion in both the domains. Other biophysical
properties could be simulated in the future for the construc-
tion of real patient models, which could include blood vessels
and the heat-sink effect due to blood flow at or near the tumor
site. In the present study, FEM modeling was followed by
repeating the simulation procedure on non-cancerous breast
tissue. This was also used to evaluate the performance of the
electrode (see results in Table 3).
Experimental validation
For this, the same gel phantom and the RITA electrode were
used (Fig. 4a), and the environmental conditions were kept
the same. The power delivered to the electrode for sufficient
ablation was found to be 25 W that is the same as that in
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Table 3 Volume and size measurements of RFA ablation versus FEM analysis in two RFA needles
Applied energy Q (kJ) Longitudinal ablation size L (cm) Transversal ablation size W (cm) Volume∗
V (cm3)
Ablation-I 7.5 3.40 4.40 34.45
FEM-I 7.5 3.45 4.35 34.16
Ablation-II 2.25 3.4 1.49 3.94
FEM-II 2.25 3.44 1.48 3.95
Two RFA needles: I refers to RITA monopolar needle, and II refers to the bipolar needle




Fig. 4 RFA experimental validation against FEM simulation, using
the same RFA electrode and gel phantom and similar RF power and
treatment time: a the RITA electrode inserted and deployed into the gel
phantom and RFA in progress with ablated gel becoming opaque; b a
completed ablation at 5 min using 25 W: the ablated region was excised
for dimension measurement
FEM simulation in the model. Miniature thermocouple sen-
sors were used to monitor real-time temperature changes dur-
ing ablation, and these too were similar (data not shown)
to the simulation temperatures shown in Fig. 2b. The abla-
tion was carried out over 300 s, and the ablated gel region
(which opacified at temperatures over 50 ◦C) was dissected
to measure its dimension (Fig. 4b). In brief, following abla-
tion and withdrawal of the probe, the gel phantom was cut
along the longitudinal plane, passing through the probe axis.
(Additional slices can be cut along the transverse plane when
the ablation geometry is not symmetrical due to local varia-
tions caused by proximity to a large blood vessel. However,
this was not the case for this gel phantom study.) The abla-
tion zone was determined from the maximal transverse (W
in cm) and longitudinal (L in cm) dimensions: the volume
(V in cm3) was calculated using the formula for ellipsoid
volume, that is, V = (π/6)LW 2 [16].
Table 3 lists the volume and size measurements of RFA
ablation, together with FEM simulation results. Group I
(Ablation-I and FEM-I) refers to results using RITA mono-
polar probe; while group II, the data for the bipolar nee-
dle. The volume of ablation achieved is very similar to that
obtained by FEM analysis. Also the data confirm that the
RITA RF electrode can completely ablate the tumor, as dis-
tinct from the bipolar needle, which in the study could not
achieve completed ablation that would require multiple bipo-
lar needles [20].
We recognize that the model used in the present study is
simple and requires further development to a more realistic
model based on real clinical MR or CT images in order to
be useful clinically as it would need to simulate more com-
plicated geometries in surrounding tissues and organs [21].
There are also limitations inherent to ex-vitro experiments
especially as the gel phantom did not contain any vessels to
simulate blood flow and perfusion. However, there have been
reported studies that compared ex-vivo and in-vivo ablation.
Zlotta et al. [22] reported that in the in-vivo procedure, the
size of the lesions in human renal cancer was comparable
to the forecast size derived from an ex-vivo model consist-
ing of a harvested kidney with perfusion. Cha et al. [23]
reported that their laboratory studies using internally cooled
electrodes in animal models and found reduced (up to 1/3)
ablation sizes in in-vivo studies (n = 16) when compared
to the ex-vivo experiments (n = 30), 2.62 × 2.0 cm for in-
vivo and 3.01 × 2.62 cm for ex-vivo, respectively. Hence,
an advanced patient-specific 3D CAD/FEM model, with
123
948 Int J CARS (2012) 7:941–948
real-time feedback of in-situ treatment temperature and with
continuous updating of temperature-dependent tissue physi-
cal properties, is needed for more accurate simulation of RFA
pre-treatment planning designed to improve the efficacy of
clinical RFA ablation of tumors.
Conclusions
We have successfully developed and validated an image-
based 3D modeling of RFA. This pilot study indicates that
this approach to overcome the current problems encountered
in clinical RFA is promising but requires further develop-
ment with the use of clinical images obtained by CT or MRI
to construct patient-specific models for RFA planning and
simulation with a view to optimizing treatment efficacy.
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